Disrupting Drug Costs: The Role of Cost-Plus Pricing in Reducing Medicare Spending on Hypertension Treatments
{{output}}
Objective: To assess potential Medicare cost savings if Mark Cuban Cost Plus Drug Company (MCCPDC) pricing were applied to antihypertensive medications. Study set... ...
